Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring... see more

Recent & Breaking News (CSE:BUX)

BioMark Announces New Patent Granted in United States

TheNewsWire May 30, 2019

Revision on Total Funding Secured by BioMark and its Team of Collaborators on CHRP Application

TheNewsWire May 1, 2019

BioMark and its Team of Collaborators Secure CHRP Funding

TheNewsWire April 17, 2019

BioMark Closes the Private Placement Offering

TheNewsWire April 16, 2019

BioMark Announces Private Placement

TheNewsWire April 9, 2019

BioMark's Abstract Accepted for 2019 ASCO Online Publication

TheNewsWire April 3, 2019

BioMark Contributes Additional Scientific Publication

TheNewsWire March 14, 2019

BioMark Announces New Patent Granted in China

TheNewsWire March 12, 2019

Dr. Myron Weisfedlt Joins BioMark's Scientific Advisory Team

TheNewsWire November 5, 2018

BioMark Closes Final Tranche of Private Placement Offering

TheNewsWire October 4, 2018

Dr. Sandeep Singhal Joins BioMark Scientific Advisory Team

TheNewsWire October 2, 2018

BioMark Contributes in Scientific Publication

TheNewsWire September 26, 2018

Dr. Paramjit Tappia Joins BioMark Scientific Advisory Team

TheNewsWire September 19, 2018

BioMark Partners with Alberta Machine Intelligence Institute to Amplify Clinical Diagnostic Decision Making

TheNewsWire April 25, 2018

BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant

TheNewsWire February 27, 2018

BIOMARK's Health Canada Submission Update

TheNewsWire February 21, 2018

Further Progress in BIOMARK's Clinical Trial and Regulatory Review

TheNewsWire January 3, 2018

Global Affairs Canada Supports BioMark's Trip to Japan

TheNewsWire December 19, 2017

Dr. Ian Smith Joins Biomark's Board of Directors

TheNewsWire December 5, 2017

BioMarks Clinical Trial and Research Update

Filing Services Canada November 1, 2017